[144] Mettler-Toledo International SEC Filing

Rhea-AI Filing Summary

Mettler-Toledo (MTD) Form 144 discloses a proposed sale of common stock: 1,062 shares to be sold through Merrill on the NYSE with an aggregate market value reported as $1,381,560. The filing shows these shares were acquired by a stock option exercise on 11/05/2015 from Mettler Toledo and that payment for the planned sale is expected in cash on 08/13/2025. The company reports 20,599,040 shares outstanding, and the filer reports no securities sold in the past three months.

The filing includes the standard representation that the seller is not aware of undisclosed material adverse information and notes the Rule 10b5-1 trading plan language, but no plan adoption date or signature details are provided in the visible content.

Insights

Securities Analyst

TL;DR: Small, routine insider sale filing; volume is immaterial relative to outstanding shares and unlikely to move markets.

The Form 144 reports an intended sale of 1,062 common shares via Merrill on the NYSE, representing roughly 0.005% of the company's 20,599,040 shares outstanding. The shares were acquired by a stock option exercise on 11/05/2015. No prior sales in the last three months are reported. Because the disclosed position is very small versus outstanding shares and no material operational disclosures accompany the filing, the transaction appears routine and not market-moving. The filing does include the standard attestation about material adverse information; no trading-plan adoption date is shown.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 mechanics; no governance or compliance red flags evident from available content.

The notice supplies required Rule 144 details: class of security, acquisition date and method (stock option exercise from Mettler Toledo), broker (Merrill), and intended sale date (08/13/2025). The filer certifies absence of undisclosed material adverse information. There is no indication in the provided text of a signed 10b5-1 plan or any accelerated sale program date. Based on the disclosed figures and absence of recent sales, this appears to be standard compliance disclosure rather than a governance concern.

08/13/2025 - 01:08 PM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Merrill 8890 Lyra Dr 5th Flr Columbus OH 43240	1062	1381560.00	20599040	08/13/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/05/2015	Stock Option exrcise	Mettler Toledo			1062	08/13/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does MTD's Form 144 report about the proposed sale?

The filing reports a proposed sale of 1,062 common shares through Merrill on the NYSE with an aggregate market value of $1,381,560 and an approximate sale date of 08/13/2025.

When and how were the shares being sold originally acquired?

The shares were acquired by stock option exercise from Mettler Toledo on 11/05/2015.

How many MTD shares are outstanding according to the filing?

The filing shows 20,599,040 shares outstanding.

Did the filer report any securities sold in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Does the Form 144 indicate a Rule 10b5-1 trading plan was used?

The form contains the standard Rule 10b5-1 language, but the provided content does not include a trading-plan adoption date or an explicit statement that a plan was adopted.